primary liver cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patient is 18-90 years old; 2. Patients diagnosed as primary liver cancer according to the Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2022); 3. Patients with primary liver cancer who cannot be removed after surgical consultation; 4. BCLC is divided into B or C, Child Pugh scores A or B, and ECOG PS scores 0-2; 5. Expected survival time of patients = 3 months; 6. At least one measurable lesion; 7. Patients who plan to receive systematic treatment for the first time or who have experienced tumor progression by using other systematic treatments in the past; 8. The patient voluntarily participated in this clinical study, understood and signed the informed consent form, complied with the research requirements and had good compliance.
Exclusion criteria
Exclusion criteria: 1. The patient has other malignant tumors at the same time; 2. Patients with severe coagulation dysfunction or severe thrombocytopenic purpura; 3. The patients were in the active infection period of HIV, EB virus, cytomegalovirus, syphilis, tuberculosis, etc. when they were enrolled; 4. The patient has refractory ascites or severe portal hypertension; 5. The patient has severe heart, lung, kidney and other system dysfunction; 6. There are patients who are expected to have treatment interruption or cannot be evaluated for efficacy; 7. Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression free survival;tumor response; | — |
Countries
China
Contacts
The Fifth Medical Center of Chinese PLA General Hospital